Advertisement
Singapore markets closed
  • Straits Times Index

    3,297.55
    -26.98 (-0.81%)
     
  • Nikkei

    38,814.56
    +94.06 (+0.24%)
     
  • Hang Seng

    17,941.78
    -170.82 (-0.94%)
     
  • FTSE 100

    8,146.86
    -16.81 (-0.21%)
     
  • Bitcoin USD

    66,590.42
    +456.82 (+0.69%)
     
  • CMC Crypto 200

    1,382.08
    -35.79 (-2.52%)
     
  • S&P 500

    5,431.60
    -2.14 (-0.04%)
     
  • Dow

    38,589.16
    -57.94 (-0.15%)
     
  • Nasdaq

    17,688.88
    +21.28 (+0.12%)
     
  • Gold

    2,348.40
    +30.40 (+1.31%)
     
  • Crude Oil

    78.49
    -0.13 (-0.17%)
     
  • 10-Yr Bond

    4.2130
    -0.0250 (-0.59%)
     
  • FTSE Bursa Malaysia

    1,607.32
    -2.85 (-0.18%)
     
  • Jakarta Composite Index

    6,734.83
    -96.73 (-1.42%)
     
  • PSE Index

    6,383.70
    -7.13 (-0.11%)
     

Exelon (EXC) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Exelon (EXC) reported $6.04 billion in revenue for the quarter ended March 2024, representing a year-over-year increase of 8.6%. EPS of $0.69 for the same period compares to $0.70 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $5.7 billion, representing a surprise of +6.04%. The company delivered an EPS surprise of -1.43%, with the consensus EPS estimate being $0.70.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

ADVERTISEMENT

Here is how Exelon performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Operating revenues- PECO: $1.05 billion versus $1.15 billion estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -5.2% change.

  • Operating revenues- ComEd: $2.10 billion compared to the $1.78 billion average estimate based on three analysts. The reported number represents a change of +25.7% year over year.

  • Operating revenues- BGE: $1.30 billion compared to the $1.21 billion average estimate based on three analysts. The reported number represents a change of +3.2% year over year.

  • Operating revenues- PHI: $1.61 billion versus the three-analyst average estimate of $1.59 billion. The reported number represents a year-over-year change of +4.6%.

  • Natural gas revenues- BGE: $416 million versus $366.10 million estimated by two analysts on average.

  • Electric revenues- DPL: $419 million compared to the $382.38 million average estimate based on two analysts.

  • Electric revenues- ACE: $345 million compared to the $379.30 million average estimate based on two analysts.

  • Electric revenues- PHI: $1.53 billion versus $1.50 billion estimated by two analysts on average.

  • Natural gas revenues- PHI: $72 million versus the two-analyst average estimate of $82.75 million.

  • Natural gas revenues- PECO: $272 million versus the two-analyst average estimate of $251.82 million.

  • Electric revenues- BGE: $881 million versus the two-analyst average estimate of $807.85 million.

  • Electric revenues- PECO: $782 million versus $895.78 million estimated by two analysts on average.

View all Key Company Metrics for Exelon here>>>

Shares of Exelon have returned +1.8% over the past month versus the Zacks S&P 500 composite's -2.7% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Exelon Corporation (EXC) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research